Wednesday, May 20, 2009

NIH to launch drug development program to target rare and neglected diseases

The NIH is planning to launch a campaign aimed at developing and testing drugs aimed at rare and neglected diseases. According to the article, the NIH usually sticks to very basic science, and has only limited programs for developing drugs.

The initiative will aim to cooperate with the private market by sufficiently "de-risking" the process, since private companies have little financial incentive to develop drugs that only affect a small group of people, but are still subject to the grueling (and expensive) development and testing process.

The program will have approximately $24 million per year, aimed primarily at discovering and researching potential medicines to turn over to the private market for further development.

-Andrew Beck

No comments:

Post a Comment